Since my prior article, Altria's total returns have meaningfully outpaced the S&P 500 index. The company topped analysts' expectations in the third quarter. Altria could be on the cusp of an ...

Altria has targeted a certain annual dividend increase. Its core business remains under pressure. Smokeable-product volume has continued to fall. Generating income from dividends can prove very ...

Altria Group (NYSE: MO) has made a commitment to returning cash to shareholders. The company states it prioritizes consistently growing dividends, targeting a mid-single-digit percentage annual ...

If this kind of company isn't your style, you like companies that generate revenue, and even earn profits, then you may well be interested in Altria Group (NYSE:MO). Even if this company is fairly ...

Bank of America Securities analyst Lisa Lewandowski maintained a Buy rating on Altria Group (MO – Research Report) yesterday. The company’s shares closed yesterday at $50.87. Discover ...

Altria (NYSE: MO) owns the Marlboro brand, which has a roughly 41% market share in North America. That's huge and highlights the company's dominance in this geographic region. But the downside ...

I went from recommending Altria as a Sell last to now being a Strong Buy, with strong assumptions for its future revenue and earnings. Altria has a margin of safety and its upside has not yet been ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Pfizer yields 6.53% and trades at 9x earnings, while Altria offers 7.58% at 10.1x earnings. Pfizer's troubling 221% payout ratio contrasts sharply with Altria's manageable 67.3%. Altria's pricing ...